Literature DB >> 16629738

Amygdalae calcifications associated with disease duration in lipoid proteinosis.

Simone Appenzeller1, Erik Chaloult, Paulo Velho, Elemir Macedo de Souza, Verônica Zanardi Araújo, Fernando Cendes, Li Min Li.   

Abstract

OBJECTIVES: To describe imaging findings of central nervous system involvement in patients with lipoid proteinosis.
METHODS: Patients with lipoid proteinosis followed in the dermatology and neurology departments of the State University of Campinas between 2002 and 2004 were evaluated using high-resolution MRI and computerized tomography (CT).
RESULTS: We reviewed the charts of three patients (two women) with lipoid proteinosis with, ages ranging from 5 to 44 years. Symptomatic disease duration ranged from 2 to 39 years. MRI scans showed hypointense signal in FLAIR and T2 images in the amygdalae in two of three patients. Brain CT scans from two patients showed that MRI findings were calcifications. The calcification was more evident in patients with longer disease duration. Epilepsy was identified in one patient with longer disease duration. No other epileptogenic lesion was identified on MRI in this patient.
CONCLUSION: Lipoid proteinosis is associated with bilateral amygdalae calcification. These findings were more evident in patients with longer disease duration. Epilepsy, when present, may be related to these calcifications. Patients with lipoid proteinosis should be followed with MRI/CT in order to identify these abnormalities.

Entities:  

Mesh:

Year:  2006        PMID: 16629738     DOI: 10.1111/j.1552-6569.2006.00018.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  11 in total

1.  Molecular and neurological characterizations of three Saudi families with lipoid proteinosis.

Authors:  Mustafa A Salih; Khaled K Abu-Amero; Saleh Alrasheed; Ibrahim A Alorainy; Lu Liu; John A McGrath; Lionel Van Maldergem; Yasser H Al-Faky; Adel H AlSuhaibani; Darren T Oystreck; Thomas M Bosley
Journal:  BMC Med Genet       Date:  2011-02-24       Impact factor: 2.103

2.  [Micronodular thickening of eyelid margins. Initial findings of a general disease].

Authors:  C Huchzermeyer; A Ćirković; L Holbach
Journal:  Ophthalmologe       Date:  2010-10       Impact factor: 1.059

3.  Changes in cortical morphology resulting from long-term amygdala damage.

Authors:  Aaron D Boes; Sonya Mehta; David Rudrauf; Ellen Van Der Plas; Thomas Grabowski; Ralph Adolphs; Peg Nopoulos
Journal:  Soc Cogn Affect Neurosci       Date:  2011-09-06       Impact factor: 3.436

4.  Does bilateral damage to the human amygdala produce autistic symptoms?

Authors:  Lynn K Paul; Christina Corsello; Daniel Tranel; Ralph Adolphs
Journal:  J Neurodev Disord       Date:  2010-07-10       Impact factor: 4.025

5.  Amygdalae and striatum calcification in lipoid proteinosis.

Authors:  F G Gonçalves; M B de Melo; V de L Matos; F R Barra; R E Figueroa
Journal:  AJNR Am J Neuroradiol       Date:  2009-08-20       Impact factor: 3.825

6.  An Enhanced Default Approach Bias Following Amygdala Lesions in Humans.

Authors:  Laura A Harrison; Rene Hurlemann; Ralph Adolphs
Journal:  Psychol Sci       Date:  2015-09-03

7.  Lipoid proteinosis: pathognomonic clinical and radiological features.

Authors:  Rahul Ganapati Hegde; Vikas K Yadav; Vikas J Yadav; Meenakshi I Gajbhiye
Journal:  BMJ Case Rep       Date:  2014-04-10

8.  Radiologic presentation of lipoid proteinosis with symmetrical medial temporal lobe calcifications.

Authors:  Subhashree Chandrasekaran; Murali Nanjundan; Sundari Natarajan; Kannadhasan Ramadhas
Journal:  Radiol Case Rep       Date:  2016-02-17

9.  Attentional bias towards and away from fearful faces is modulated by developmental amygdala damage.

Authors:  Morteza Pishnamazi; Abbas Tafakhori; Sogol Loloee; Amirhossein Modabbernia; Vajiheh Aghamollaii; Bahador Bahrami; Joel S Winston
Journal:  Cortex       Date:  2016-04-22       Impact factor: 4.027

10.  Hypervigilance for fear after basolateral amygdala damage in humans.

Authors:  D Terburg; B E Morgan; E R Montoya; I T Hooge; H B Thornton; A R Hariri; J Panksepp; D J Stein; J van Honk
Journal:  Transl Psychiatry       Date:  2012-05-15       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.